[1] |
Torre LA, Bray F, Siegel RL , et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108.
doi: 10.3322/caac.21262
URL
|
[2] |
Tota JE, Anderson WF, Coffey C , et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012[J]. Oral Oncol, 2017,67:146-152.
doi: 10.1016/j.oraloncology.2017.02.019
URL
|
[3] |
Siegel RL, Miller KD, Jemal A . Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1):7-34.
|
[4] |
Li R, Koch WM, Fakhry C , et al. Distinct epidemiologic characteristics of oral tongue cancer patients[J]. Otolaryngol Head Neck Surg, 2013,148(5):792-796.
|
[5] |
Jansen L, Buttmann-Schweiger N, Listl S , et al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site[J]. Oral Oncol, 2018,76:8-15.
|
[6] |
Li Y, Wang HY, Zheng XF . Rab1 GTPases as oncogene[J]. Aging, 2015,7(11):897-898.
doi: 10.18632/aging.v7i11
URL
|
[7] |
Thomas JD, Zhang YJ, Wei YH , et al. Rab1A is an mTORC1 activator and a colorectal oncogene[J]. Cancer cell, 2016,30(1):181-182.
doi: 10.1016/j.ccell.2016.06.014
URL
|
[8] |
Xu BH, Li XX, Yang Y , et al. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A[J]. Oncotarget, 2015,6(25):20813-20828.
doi: 10.18632/oncotarget.v6i25
URL
|
[9] |
Bao ZS, Li MY, Wang JY , et al. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling[J]. CNS Neurosci Ther, 2014,20(2):112-118.
doi: 10.1111/cns.12171
URL
|
[10] |
Shimada K, Uzawa K, Kato M , et al. Aberrant expression of RAB1A in human tongue cancer[J]. Br J Cancer, 2005,92(10):1915-1921.
|
[11] |
Yin C, Mou Q, Pan X , et al. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25[J]. Thorac Cancer, 2018,9(4):472-479.
doi: 10.1111/tca.2018.9.issue-4
URL
|
[12] |
Yin C, Zhang G, Sun R , et al. miR-185-5p inhibits F-actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE[J]. Mol Med Rep, 2018,18(3):2621-2630.
|
[13] |
Charng WL, Yamamoto S, Jaiswal M , et al. Drosophila Tempura, a novel protein prenyltransferase αsubunit, regulates notch signaling via Rab1 and Rab11[J]. PLoS Biol, 2014,12(1):e1001777.
doi: 10.1371/journal.pbio.1001777
URL
|
[14] |
Bucci C, Alifano P . The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors[J]. Membranes, 2014,4(4):642-677.
doi: 10.3390/membranes4040642
URL
|
[15] |
Quan Y, Song Q, Wang J , et al. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A[J]. Tumor Biol, 2017,39(4):1-10.
|
[16] |
Zhang CZ, Cao Y, Fu J , et al. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33[J]. Mol Oncol, 2016,10(10):1532-1541.
|
[17] |
Xu H, Qian M, Zhao B , et al. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells[J]. Oncol Rep, 2017,37(3):1619-1626.
|
[18] |
Xie S, Lu Z, Lin Y , et al. Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer cells through repression of epithelial-mesenchymal transition (EMT)[J]. Tumor Biol, 2016,37(5):6681-6689.
|
[19] |
Huang W, Cui X, Chen J , et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition[J]. Oncotarget, 2016,7(38):62520-62532.
doi: 10.18632/oncotarget.v7i38
URL
|
[20] |
Fang Z, Zhang S, Wang Y , et al. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins[J]. BMC cancer, 2016,16(9):706.
|
[21] |
Liang J, Liang L, Ouyang K , et al. MALAT1 induces tongue cancer cells’ EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway[J]. J Oral Pathol Med, 2017,46(2):98-105.
doi: 10.1111/jop.2017.46.issue-2
URL
|